Lmh Strategic Solutions
Lmh Strategic Solutions is a lobbying firm that has earned $3.1M in lobbying income across 86 filings, representing 23 clients over 2 years (2024–2025). The firm employs 2 lobbyists across 4 policy issue areas.
🤖
AI Overview
Lmh Strategic Solutions has earned $3.1M in lobbying income across 86 filings, representing 23 clients. It is an active participant in federal lobbying. across 4 policy areas. Active from 2024 to 2025.
$3.1M
Total Income
23
Clients
2
Lobbyists
86
Filings
Income by Year
| Year | Lobbying Income |
|---|---|
| 2024 | $570K |
| 2025 | $2.5M |
Clients (23)
Orchard Therapeutics North AmericaAvadel Pharmaceuticals, PLCPharmaceutical Research and Manufacturers of AmericaMedical Device Manufacturers AssociationGlaxosmithkline LLCIonis Pharmaceuticals, INC.Alkermes, INC.Rare Disease Company CoalitionAlnylam Pharmaceuticals, INC.Erisa Industry Committee (Eric)Stealth Biotherapeutics INC.Neuropace, INC.Ptc Therapeutics, INC.Acadia PharmaceuticalsNeurocrine Biosciences, INC.Regenxbio INC.Travere Therapeutics, INC.Biomarin Pharmaceutical, INC.Ardelyx, INC.Exelixis, INC.Harmony BiosciencesIncyte CorporationSavara INC.
Lobbyists (2)
Issue Areas (4)
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
The 22,000% ROI
When lobbying spending yields outsized returns.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.